Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease

por Tashkin, Donald P, Wechsler, Michael E
Publicado 2018

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines

por Westreich, Aaron, Zelarney, Pearlanne, Wechsler, Michael E.
Publicado 2023

Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?

por Menzies-Gow, Andrew, Wechsler, Michael E., Brightling, Chris E.
Publicado 2020

Restarting Respiratory Clinical Research in the Era of the Coronavirus Disease 2019 Pandemic

por Taylor-Cousar, Jennifer L., Maier, Lisa, Downey, Gregory P., Wechsler, Michael E.
Publicado 2021

Sex and gender in asthma

por Chowdhury, Nowrin U., Guntur, Vamsi P., Newcomb, Dawn C., Wechsler, Michael E.
Publicado 2021

Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis

por Liao, Shu-Yi, Gerber, Anthony N., Zelarney, Pearlanne, Make, Barry, Wechsler, Michael E.
Publicado 2022

SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis

por Liao, Shu-Yi, Gerber, Anthony N., Zelarney, Pearlanne, Make, Barry, Wechsler, Michael E.
Publicado 2022

Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases

por Strobel, Mary Jo, Alves, Debbie, Roufosse, Florence, Antoun, Zeina, Kwon, Namhee, Baylis, Lee, Wechsler, Michael E
Publicado 2022

Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients

por Liu, Haolin, Aviszus, Katja, Zelarney, Pearlanne, Liao, Shu-Yi, Gerber, Anthony N., Make, Barry, Wechsler, Michael E., Marrack, Philippa, Reinhardt, R. Lee
Publicado 2023

Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis

por Condreay, Lynn D., Parham, Laura R., Qu, Xiaoyan A., Steinfeld, Jonathan, Wechsler, Michael E., Raby, Benjamin A., Yancey, Steven W., Ghosh, Soumitra
Publicado 2020

Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients

por Liu, Haolin, Aviszus, Katja, Zelarney, Pearlanne, Liao, Shu-Yi, Gerber, Anthony N., Make, Barry, Wechsler, Michael E., Marrack, Philippa, Reinhardt, R. Lee
Publicado 2023

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma

por Bleecker, Eugene R., Wechsler, Michael E., FitzGerald, J. Mark, Menzies-Gow, Andrew, Wu, Yanping, Hirsch, Ian, Goldman, Mitchell, Newbold, Paul, Zangrilli, James G.
Publicado 2018

Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review

por Keskin, Ozlem, Farzan, Niloufar, Birben, Esra, Akel, Hayriye, Karaaslan, Cagatay, Maitland-van der Zee, Anke H., Wechsler, Michael E., Vijverberg, Susanne J., Kalayci, Omer
Publicado 2019

SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroi...

por Wechsler, Michael E., Colice, Gene, Griffiths, Janet M., Almqvist, Gun, Skärby, Tor, Piechowiak, Teresa, Kaur, Primal, Bowen, Karin, Hellqvist, Åsa, Mo, May, Garcia Gil, Esther
Publicado 2020

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype

por Terrier, Benjamin, Jayne, David R.W., Hellmich, Bernhard, Bentley, Jane H., Steinfeld, Jonathan, Yancey, Steven W., Kwon, Namhee, Akuthota, Praveen, Khoury, Paneez, Baylis, Lee, Wechsler, Michael E.
Publicado 2023

LTC(4) synthase polymorphism modifies efficacy of botanical seed oil combination in asthma

por Kazani, Shamsah, Arm, Jonathan P, Boyce, Joshua, Chhay, Heng, Dutile, Stefanie, Wechsler, Michael E, Govindarajulu, Usha, Ivester, Priscilla, Ainsworth, Hannah C, Sergeant, Susan, Chilton, Floyd H, Israel, Elliot
Publicado 2014

Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design

por De Prado Gomez, Lucia, Pavord, Ian, Busse, William, Brightling, Christopher E., Wechsler, Michael E., Rabe, Klaus F., Zhang, Mei, Xing, Jun, Jacob-Nara, Juby A., Rowe, Paul J.
Publicado 2023

Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose

por Domingo, Christian, Rabe, Klaus F., Price, David, Brusselle, Guy, Wechsler, Michael E., Xia, Changming, Pandit-Abid, Nami, Gall, Rebecca, Rowe, Paul J., Deniz, Yamo, Jacob-Nara, Juby A., Radwan, Amr
Publicado 2023

Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL(−1)

por Rabe, Klaus F., Pavord, Ian D., Castro, Mario, Wechsler, Michael E., Daizadeh, Nadia, Kapoor, Upender, Ortiz, Benjamin, Radwan, Amr, Johnson, Robert R., Rowe, Paul J., Deniz, Yamo, Jacob-Nara, Juby A.
Publicado 2022

From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases

por Pavord, Ian D., Bel, Elisabeth H., Bourdin, Arnaud, Chan, Robert, Han, Joseph K., Keene, Oliver N., Liu, Mark C., Martin, Neil, Papi, Alberto, Roufosse, Florence, Steinfeld, Jonathan, Wechsler, Michael E., Yancey, Steven W.
Publicado 2021